IDentif.AI: Rapidly optimizing combination therapy design against severe Acute Respiratory Syndrome Coronavirus 2 (SARS-Cov-2) with digital drug development

10.1002/btm2.10196

Saved in:

Bibliographic Details
Main Authors:	Blasiak, Agata, Lim, Jhin Jieh, Seah, Shirley Gek Kheng, Kee, Theodore, Remus, Alexandria, Chye, De Hoe, Wong, Pui San, Hooi, Lissa, Truong, Anh T. L., Le, Nguyen, Chan, Conrad E. Z., Desai, Rishi, Ding, Xianting, Hanson, Brendon J., Chow, Edward Kai-Hua, Ho, Dean
Other Authors:	BIOMEDICAL ENGINEERING
Format:	Article
Published:	Blackwell Publishing Ltd 2022
Subjects:	artificial intelligence combinatory treatment COVID-19 digital medicine drug development drug interactions SARS-CoV-2
Online Access:	https://scholarbank.nus.edu.sg/handle/10635/232881
Tags:	Add Tag No Tags, Be the first to tag this record!
Institution:	National University of Singapore

id	sg-nus-scholar.10635-232881
record_format	dspace
spelling	sg-nus-scholar.10635-2328812024-04-25T02:05:40Z IDentif.AI: Rapidly optimizing combination therapy design against severe Acute Respiratory Syndrome Coronavirus 2 (SARS-Cov-2) with digital drug development Blasiak, Agata Lim, Jhin Jieh Seah, Shirley Gek Kheng Kee, Theodore Remus, Alexandria Chye, De Hoe Wong, Pui San Hooi, Lissa Truong, Anh T. L. Le, Nguyen Chan, Conrad E. Z. Desai, Rishi Ding, Xianting Hanson, Brendon J. Chow, Edward Kai-Hua Ho, Dean BIOMEDICAL ENGINEERING CANCER SCIENCE INSTITUTE OF SINGAPORE SURGERY PHARMACOLOGY COLLEGE OF DESIGN AND ENGINEERING artificial intelligence combinatory treatment COVID-19 digital medicine drug development drug interactions SARS-CoV-2 10.1002/btm2.10196 Bioengineering and Translational Medicine 6 1 e10196 2022-10-13T01:16:42Z 2022-10-13T01:16:42Z 2020-12-01 Article Blasiak, Agata, Lim, Jhin Jieh, Seah, Shirley Gek Kheng, Kee, Theodore, Remus, Alexandria, Chye, De Hoe, Wong, Pui San, Hooi, Lissa, Truong, Anh T. L., Le, Nguyen, Chan, Conrad E. Z., Desai, Rishi, Ding, Xianting, Hanson, Brendon J., Chow, Edward Kai-Hua, Ho, Dean (2020-12-01). IDentif.AI: Rapidly optimizing combination therapy design against severe Acute Respiratory Syndrome Coronavirus 2 (SARS-Cov-2) with digital drug development. Bioengineering and Translational Medicine 6 (1) : e10196. ScholarBank@NUS Repository. https://doi.org/10.1002/btm2.10196 2380-6761 https://scholarbank.nus.edu.sg/handle/10635/232881 Attribution 4.0 International https://creativecommons.org/licenses/by/4.0/ Blackwell Publishing Ltd Scopus OA2021
institution	National University of Singapore
building	NUS Library
continent	Asia
country	Singapore Singapore
content_provider	NUS Library
collection	ScholarBank@NUS
topic	artificial intelligence combinatory treatment COVID-19 digital medicine drug development drug interactions SARS-CoV-2
spellingShingle	artificial intelligence combinatory treatment COVID-19 digital medicine drug development drug interactions SARS-CoV-2 Blasiak, Agata Lim, Jhin Jieh Seah, Shirley Gek Kheng Kee, Theodore Remus, Alexandria Chye, De Hoe Wong, Pui San Hooi, Lissa Truong, Anh T. L. Le, Nguyen Chan, Conrad E. Z. Desai, Rishi Ding, Xianting Hanson, Brendon J. Chow, Edward Kai-Hua Ho, Dean IDentif.AI: Rapidly optimizing combination therapy design against severe Acute Respiratory Syndrome Coronavirus 2 (SARS-Cov-2) with digital drug development
description	10.1002/btm2.10196
author2	BIOMEDICAL ENGINEERING
author_facet	BIOMEDICAL ENGINEERING Blasiak, Agata Lim, Jhin Jieh Seah, Shirley Gek Kheng Kee, Theodore Remus, Alexandria Chye, De Hoe Wong, Pui San Hooi, Lissa Truong, Anh T. L. Le, Nguyen Chan, Conrad E. Z. Desai, Rishi Ding, Xianting Hanson, Brendon J. Chow, Edward Kai-Hua Ho, Dean
format	Article
author	Blasiak, Agata Lim, Jhin Jieh Seah, Shirley Gek Kheng Kee, Theodore Remus, Alexandria Chye, De Hoe Wong, Pui San Hooi, Lissa Truong, Anh T. L. Le, Nguyen Chan, Conrad E. Z. Desai, Rishi Ding, Xianting Hanson, Brendon J. Chow, Edward Kai-Hua Ho, Dean
author_sort	Blasiak, Agata
title	IDentif.AI: Rapidly optimizing combination therapy design against severe Acute Respiratory Syndrome Coronavirus 2 (SARS-Cov-2) with digital drug development
title_short	IDentif.AI: Rapidly optimizing combination therapy design against severe Acute Respiratory Syndrome Coronavirus 2 (SARS-Cov-2) with digital drug development
title_full	IDentif.AI: Rapidly optimizing combination therapy design against severe Acute Respiratory Syndrome Coronavirus 2 (SARS-Cov-2) with digital drug development
title_fullStr	IDentif.AI: Rapidly optimizing combination therapy design against severe Acute Respiratory Syndrome Coronavirus 2 (SARS-Cov-2) with digital drug development
title_full_unstemmed	IDentif.AI: Rapidly optimizing combination therapy design against severe Acute Respiratory Syndrome Coronavirus 2 (SARS-Cov-2) with digital drug development
title_sort	identif.ai: rapidly optimizing combination therapy design against severe acute respiratory syndrome coronavirus 2 (sars-cov-2) with digital drug development
publisher	Blackwell Publishing Ltd
publishDate	2022
url	https://scholarbank.nus.edu.sg/handle/10635/232881
_version_	1800915641402654720

IDentif.AI: Rapidly optimizing combination therapy design against severe Acute Respiratory Syndrome Coronavirus 2 (SARS-Cov-2) with digital drug development

Similar Items